secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001799191-23-000042
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Ravi Sarin resigns from The Oncology Institute board; no disagreement cited
--------------------------------------------------------------------------------

- Ravi Sarin resigned from the Board on August 31, 2023, effective immediately.
- Resignation not related to any disagreement with the Company on operations, policies, or practices.
- Sarin served on Audit, Compensation, and Compliance Committees; replacements to be considered.
- Board size reduced to eight directors following Mr. Sarin's departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000042/0001799191-23-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000042/toi-20230901.htm
  HTML page:      https://secwatch.observer/filing/0001799191-23-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer